Lovastatin reduces renal vascular reactivity in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 11, Issue 10 I, 1998, Pages 1222-1231

  Jiang, Jian ^a   Sun, Chen Wen ^a   Alonso Galicia, Magdalena ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Hypertension; Lovastatin; Renal vascular tone; Small G proteins

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HYDRALAZINE; MEVINOLIN; NORADRENALIN; RAS PROTEIN; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY MEDULLA; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE CULTURE;

ANIMALS; ARTERIOLES; BLOOD PRESSURE; GTP-BINDING PROTEINS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LOVASTATIN; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RENAL CIRCULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASOMOTOR SYSTEM; VASOPRESSINS;

EID: 0031787112     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00143-5     Document Type: Article

References (32)

1. Castelli WP, Anderson K: A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986;80(2A):23-36.
2. Kannel WB: Hypertension: relationship with other risk factors. Drugs 1986;109:581-585.
3. Jiang J, Roman RJ: Lovastatin prevents the development of hypertension in spontaneously hypertensive rats. Hypertension 1997;30:968-974.
4. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990;343:425-430.
5. Habenicht AJR, Glomset JA, Ross R: Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 1980;225: 5134-5140.
6. Fairbanks KP, Witte LD, Goodman DS: Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J Biol Chem 1984;259:1546-1551.
7. O'Donnell MP, Kasiske BL, Kim Y, et al: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 1993;91:83-87.
8. Munro E, Patel PJ, Chan P, et al: Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Euro J Clin Invest 1994;24:766-772.
9. Hall A: The cellular functions of small GTP-binding proteins. Science 1990;249:635-640.
10. Collin C, Paragevnge AG, Lowry DR, Alkon DL: Early enhancement of calcium currents by H-ras oncoproteins injected into Hermissenda neurons. Science 1990; 250:1743-1745.
11. Hirata K, Kikuchi A, Sasaki T, et al: Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992;267:8719-8722.
12. 2+-responsiveness of smooth muscle contraction. FEBS Lett 1993;324:211-215.
13. Ito O, Alonso-Galicia M, Hoop KA, Roman RJ: Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol 1998;274:F395-F404.
14. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
15. Kost CK Jr, Herzer WA, Li P, Jackson EK: Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Therap 1993;269:82-88.
16. 1-adrenergic receptor responsiveness. Am J Physiol 1991;260:R889-R893.
17. Roman RJ: Altered pressure-natriuresis relationship in young spontaneously hypertensive rats. Hypertension 1987;9(suppl III):III-130-III-136.
18. Roman RJ, Kaldunski ML: Renal cortical and papillary blood flow in spontaneously hypertensive rats. Hypertension 1988;11:657-663.
19. Iritani N, Fukuda E, Nara Y, Yamori Y: Lipid metabolism in spontaneously hypertensive rats (SHR). Atherosclerosis 1977;28:217-222.
20. Kawahara Y, Kawata M, Sunako M, et al: Identification of a major GTP-binding protein in bovine aortic smooth muscle cytosol as the rhoA gene product. Biochem Biophys Res Comm 1990;170:673-683.
21. Itoh T, Kaibuchi K, Masuda T, et al: The post-translational processing of ras p21 is critical for its stimulation of mitogen-activated protein kinase. J Biol Chem 1993; 268:3025-3028.
22. Mizuno T, Kaibuchi K, Yamamoto T, et al: A stimulatory GDP/GTP exchange protein for small G p21 is active on the post-translationally processed form of c-Ki-ras p21 and rho A p21. Proc Natl Acad Sci USA 1991;88:6442-6446.
23. Feleszko W, Lasek W, Golab J, Jakobisiak M: Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice. Neoplasma 1995;42:69-74.
24. Soma MR, Donetti E, Parolini C, et al: HMG-CoA reductase inhibitors: in vivo effects on carotid intimai thickening in normocholesterolemic rabbits. Arterioscler Thromb 1993;13:571-578.
25. Hodis HN, Mack WJ, LaBree L, et al: Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann Intern Med 1996;124:548-556.
26. + channels. Cell 1990;61:769-776.
27. 2+ responses in rat A10 vascular smooth muscle cells. Circ Res 1994;74:173-181.
28. Imig JD, Falck JR, Gebremedhin D, et al: Elevated renal vascular tone in young spontaneously hypertensive rats. Role of cytochrome 450. Hypertension 1993;22: 357-364.
29. Eccleston-Joyner CA, Gray SD: Arterial hypertrophy in the fetal and neonatal spontaneously hypertensive rat. Hypertension 1988;12:513-518.
30. Smeda JS, Lee RMKW, Forrest JB: Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res 1988;63:534-543.
31. Kett MM, Alcorn D, Bertram JF, Anderson WP: Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats. Hypertension 1995; 25:335-342.
32. Clark CJ, Milligan G, McLellan AR, Connell JMC: Guanine nucleotide regulatory protein levels and function in spontaneously hypertensive rat vascular smooth muscle cells. Biochem Biophys Acta 1992;1136:290-296.